Genetic alterations of serous borderline tumors of the ovary compared to stage I serous ovarian carcinomas

Cancer Genetics and Cytogenetics

Volumn 167, Issue 2, 2006, Pages 103-108

  Österberg, Lovisa ^a   Åkeson, Margaretha ^b   Levan, Kristina ^a   Partheen, Karolina ^a   Zetterqvist, Britt Marie ^b   Brännström, Mats ^a   Horvath, György ^a,c  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b Södra Älvsborgs Sjukhus ^*  (Sweden)

^c SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER STAGING; CARCINOGENESIS; CHROMOSOME 12P; CHROMOSOME 17; CHROMOSOME 18P; CHROMOSOME 20Q; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; CYTOGENETICS; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; OVARY CARCINOMA; OVARY TUMOR; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANEUPLOIDY; CARCINOMA; DNA, NEOPLASM; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM STAGING; NUCLEIC ACID HYBRIDIZATION; OVARIAN NEOPLASMS; SEROUS MEMBRANE;

EID: 33744914306     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2006.01.009     Document Type: Article

References (30)

1. Trope C., and Kaern J. Management of borderline tumors of the ovary: state of the art. Semin Oncol 25 (1998) 372-380
2. Heintz A.P., Odicino F., Maisonneuve P., Beller U., Benedet J.L., Creasman W.T., Ngan H.Y., and Pecorelli S. Carcinoma of the ovary. Int J Gynaecol Obstet (2003) 83(Suppl)1:135-66
3. Sherman M.E., Mink P.J., Curtis R., Cote T.R., Brooks S., Hartge P., and Devesa S. Survival among women with borderline ovarian tumors and ovarian carcinoma: a population-based analysis. Cancer 100 (2004) 1045-1052
4. Trimble C.L., Kosary C., and Trimble E.L. Long-term survival and patterns of care in women with ovarian tumors of low malignant potential. Gynecol Oncol 86 (2002) 34-37
5. Link Jr. C.J., Reed E., Sarosy G., and Kohn E.C. Borderline ovarian tumors. Am J Med 101 (1996) 217-225
6. Seidman J.D., and Kurman R.J. Ovarian serous borderline tumors: a critical review of the literature with emphasis on prognostic indicators. Hum Pathol 31 (2000) 539-557
7. Kaern J., Trope C.G., Kristensen G.B., Abeler V.M., and Pettersen E.O. DNA ploidy; the most important prognostic factor in patients with borderline tumors of the ovary. Int J Gynecol Cancer 3 (1993) 349-358
8. Padberg B.C., Arps H., Franke U., Thiedemann C., Rehpenning W., Stegner H.E., Lietz H., Schroder S., and Dietel M. DNA cytophotometry and prognosis in ovarian tumors of borderline malignancy. A clinicomorphologic study of 80 cases. Cancer 69 (1992) 2510-2514
9. Seidman J.D., Norris H.J., Griffin J.L., and Hitchcock C.L. DNA flow cytometric analysis of serous ovarian tumors of low malignant potential. Cancer 71 (1993) 3947-3951
10. Demirel D., Laucirica R., Fishman A., Owens R.G., Grey M.M., Kaplan A.L., and Ramzy I. Ovarian tumors of low malignant potential. Correlation of DNA index and S-phase fraction with histopathologic grade and clinical outcome. Cancer 77 (1996) 1494-1500
11. Buttin B.M., Herzog T.J., Powell M.A., Rader J.S., and Mutch D.G. Epithelial ovarian tumors of low malignant potential: the role of microinvasion. Obstet Gynecol 99 (2002) 11-17
12. Trope C., and Kaern J. Prognosis and management of borderline tumours of the ovary. Curr Opin Obstet Gynecol 8 (1996) 12-16
13. Leake J.F. Tumors of low malignant potential. Curr Opin Obstet Gynecol 4 (1992) 81-85
14. Hu J., Khanna V., Jones M.M., and Surti U. Genomic imbalances in ovarian borderline serous and mucinous tumors. Cancer Genet Cytogenet 139 (2002) 18-23
15. Blegen H., Einhorn N., Sjovall K., Roschke A., Ghadimi B.M., McShane L.M., Nilsson B., Shah K., Ried T., and Auer G. Prognostic significance of cell cycle proteins and genomic instability in borderline, early and advanced stage ovarian carcinomas. Int J Gynecol Cancer 10 (2000) 477-487
16. Wolf N.G., Abdul-Karim F.W., Farver C., Schrock E., du Manoir S., and Schwartz S. Analysis of ovarian borderline tumors using comparative genomic hybridization and fluorescence in situ hybridization. Genes Chromosomes Cancer 25 (1999) 307-315
17. Tibiletti M.G., Bernasconi B., Taborelli M., Facco C., Riva C., Capella C., Franchi M., Binelli G., Acquati F., and Taramelli R. Genetic and cytogenetic observations among different types of ovarian tumors are compatible with a progression model underlying ovarian tumorigenesis. Cancer Genet Cytogenet 146 (2003) 145-153
18. Osterberg L., Levan K., Partheen K., Helou K., and Horvath G. Cytogenetic analysis of carboplatin resistance in early-stage epithelial ovarian carcinoma. Cancer Genet Cytogenet 163 (2005) 144-150
19. Kallioniemi O.P., Kallioniemi A., Piper J., Isola J., Waldman F.M., Gray J.W., and Pinkel D. Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors. Genes Chromosomes Cancer 10 (1994) 231-243
20. Staebler A., Heselmeyer-Haddad K., Bell K., Riopel M., Perlman E., Ried T., and Kurman R.J. Micropapillary serous carcinoma of the ovary has distinct patterns of chromosomal imbalances by comparative genomic hybridization compared with atypical proliferative serous tumors and serous carcinomas. Hum Pathol 33 (2002) 47-59
21. Pejovic T., Iosif C.S., Mitelman F., and Heim S. Karyotypic characteristics of borderline malignant tumors of the ovary: trisomy 12, trisomy 7, and r(1) as nonrandom features. Cancer Genet Cytogenet 92 (1996) 95-98
22. Kohlberger P.D., Kieback D.G., Mian C., Wiener H., Kainz C., Gitsch G., and Breitenecker G. Numerical chromosomal aberrations in borderline, benign, and malignant epithelial tumors of the ovary: correlation with p53 protein overexpression and Ki-67. J Soc Gynecol Investig 4 (1997) 262-264
23. Partheen K., Levan K., Osterberg L., Helou K., and Horvath G. Analysis of cytogenetic alterations in stage III serous ovarian adenocarcinoma reveals a heterogeneous group regarding survival, surgical outcome, and substage. Genes Chromosomes Cancer 40 (2004) 342-348
24. Zanotti K.M., Hart W.R., Kennedy A.W., Belinson J.L., and Casey G. Allelic imbalance on chromosome 17p13 in borderline (low malignant potential) epithelial ovarian tumors. Int J Gynecol Pathol 18 (1999) 247-253
25. Sonoda G., Palazzo J., du Manoir S., Godwin A.K., Feder M., Yakushiji M., and Testa J.R. Comparative genomic hybridization detects frequent overrepresentation of chromosomal material from 3q26, 8q24, and 20q13 in human ovarian carcinomas. Genes Chromosomes Cancer 20 (1997) 320-328
26. Arnold N., Hagele L., Walz L., Schempp W., Pfisterer J., Bauknecht T., and Kiechle M. Overrepresentation of 3q and 8q material and loss of 18q material are recurrent findings in advanced human ovarian cancer. Genes Chromosomes Cancer 16 (1996) 46-54
27. Shridhar V., Lee J., Pandita A., Iturria S., Avula R., Staub J., Morrissey M., Calhoun E., Sen A., Kalli K., Keeney G., Roche P., Cliby W., Lu K., Schmandt R., Mills G.B., Bast Jr. R.C., James C.D., Couch F.J., Hartmann L.C., Lillie J., and Smith D.I. Genetic analysis of early- versus late-stage ovarian tumors. Cancer Res 61 (2001) 5895-5904
28. Link Jr. C.J., Kohn E., and Reed E. The relationship between borderline ovarian tumors and epithelial ovarian carcinoma: epidemiologic, pathologic, and molecular aspects. Gynecol Oncol 60 (1996) 347-354
29. Shih I.M., and Kurman R.J. Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis. Am J Pathol 164 (2004) 1511-1518
30. Zitzelsberger H., Lehmann L., Werner M., and Bauchinger M. Comparative genomic hybridisation for the analysis of chromosomal imbalances in solid tumours and haematological malignancies. Histochem Cell Biol 108 (1997) 403-417